{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T19:48:32Z","timestamp":1772826512663,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2020,6,20]],"date-time":"2020-06-20T00:00:00Z","timestamp":1592611200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,20]],"date-time":"2020-06-20T00:00:00Z","timestamp":1592611200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 81701143"],"award-info":[{"award-number":["No. 81701143"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s12035-020-01978-3","type":"journal-article","created":{"date-parts":[[2020,6,20]],"date-time":"2020-06-20T20:12:39Z","timestamp":1592683959000},"page":"3658-3670","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Ischemic Preconditioning Upregulates Decoy Receptors to Protect SH-SY5Y Cells from OGD Induced Cellular Damage by Inhibiting TRAIL Pathway and Agitating PI3K\/Akt Pathway"],"prefix":"10.1007","volume":"57","author":[{"given":"Wei","family":"Jin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1513-9609","authenticated-orcid":false,"given":"Wei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuan-cheng","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,20]]},"reference":[{"issue":"5","key":"1978_CR1","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/0361-9230(92)90123-f","volume":"29","author":"H Kato","year":"1992","unstructured":"Kato H, Araki T, Murase K, Kogure K (1992) Induction of tolerance to ischemia: alterations in second-messenger systems in the gerbil hippocampus. Brain Res Bull 29(5):559\u2013565. https:\/\/doi.org\/10.1016\/0361-9230(92)90123-f","journal-title":"Brain Res Bull"},{"issue":"3","key":"1978_CR2","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1161\/01.STR.0000115767.17923.6A","volume":"35","author":"S Wegener","year":"2004","unstructured":"Wegener S, Gottschalk B, Jovanovic V, Knab R, Fiebach JB, Schellinger PD, Kucinski T, Jungehulsing GJ et al (2004) Transient ischemic attacks before ischemic stroke: preconditioning the human brain? A multicenter magnetic resonance imaging study. Stroke 35(3):616\u2013621. https:\/\/doi.org\/10.1161\/01.STR.0000115767.17923.6A","journal-title":"Stroke"},{"issue":"6","key":"1978_CR3","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/nrn1927","volume":"7","author":"JM Gidday","year":"2006","unstructured":"Gidday JM (2006) Cerebral preconditioning and ischaemic tolerance. Nat Rev Neurosci 7(6):437\u2013448. https:\/\/doi.org\/10.1038\/nrn1927","journal-title":"Nat Rev Neurosci"},{"issue":"4","key":"1978_CR4","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/S1474-4422(09)70054-7","volume":"8","author":"U Dirnagl","year":"2009","unstructured":"Dirnagl U, Becker K, Meisel A (2009) Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use. Lancet Neurol 8(4):398\u2013412. https:\/\/doi.org\/10.1016\/S1474-4422(09)70054-7","journal-title":"Lancet Neurol"},{"issue":"2 Suppl","key":"1978_CR5","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1161\/01.STR.0000251444.56487.4c","volume":"38","author":"MP Stenzel-Poore","year":"2007","unstructured":"Stenzel-Poore MP, Stevens SL, King JS, Simon RP (2007) Preconditioning reprograms the response to ischemic injury and primes the emergence of unique endogenous neuroprotective phenotypes: a speculative synthesis. Stroke 38(2 Suppl):680\u2013685. https:\/\/doi.org\/10.1161\/01.STR.0000251444.56487.4c","journal-title":"Stroke"},{"issue":"9716","key":"1978_CR6","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/S0140-6736(09)62001-8","volume":"375","author":"HE Botker","year":"2010","unstructured":"Botker HE, Kharbanda R, Schmidt MR, Bottcher M, Kaltoft AK, Terkelsen CJ, Munk K, Andersen NH et al (2010) Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial. Lancet 375(9716):727\u2013734. https:\/\/doi.org\/10.1016\/S0140-6736(09)62001-8","journal-title":"Lancet"},{"issue":"4","key":"1978_CR7","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.neuroscience.2007.11.056","volume":"151","author":"C Ren","year":"2008","unstructured":"Ren C, Gao X, Steinberg GK, Zhao H (2008) Limb remote-preconditioning protects against focal ischemia in rats and contradicts the dogma of therapeutic time windows for preconditioning. Neuroscience 151(4):1099\u20131103. https:\/\/doi.org\/10.1016\/j.neuroscience.2007.11.056","journal-title":"Neuroscience"},{"issue":"4","key":"1978_CR8","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1007\/s13311-016-0465-z","volume":"13","author":"A McDonough","year":"2016","unstructured":"McDonough A, Weinstein JR (2016) Neuroimmune response in ischemic preconditioning. Neurotherapeutics 13(4):748\u2013761. https:\/\/doi.org\/10.1007\/s13311-016-0465-z","journal-title":"Neurotherapeutics"},{"issue":"3","key":"1978_CR9","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1161\/STROKEAHA.107.497412","volume":"39","author":"J Zhang","year":"2008","unstructured":"Zhang J, Yang ZJ, Klaus JA, Koehler RC, Huang J (2008) Delayed tolerance with repetitive transient focal ischemic preconditioning in the mouse. Stroke 39(3):967\u2013974. https:\/\/doi.org\/10.1161\/STROKEAHA.107.497412","journal-title":"Stroke"},{"issue":"3","key":"1978_CR10","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1111\/j.1750-3639.2002.tb00452.x","volume":"12","author":"MB Graeber","year":"2002","unstructured":"Graeber MB, Moran LB (2002) Mechanisms of cell death in neurodegenerative diseases: fashion, fiction, and facts. Brain Pathol 12(3):385\u2013390. https:\/\/doi.org\/10.1111\/j.1750-3639.2002.tb00452.x","journal-title":"Brain Pathol"},{"issue":"6","key":"1978_CR11","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1006\/nbdi.2001.0449","volume":"8","author":"TT Rohn","year":"2001","unstructured":"Rohn TT, Head E, Nesse WH, Cotman CW, Cribbs DH (2001) Activation of caspase-8 in the Alzheimer\u2019s disease brain. Neurobiol Dis 8(6):1006\u20131016. https:\/\/doi.org\/10.1006\/nbdi.2001.0449","journal-title":"Neurobiol Dis"},{"issue":"1","key":"1978_CR12","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1006\/excr.2000.4835","volume":"256","author":"SB Bratton","year":"2000","unstructured":"Bratton SB, MacFarlane M, Cain K, Cohen GM (2000) Protein complexes activate distinct caspase cascades in death receptor and stress-induced apoptosis. Exp Cell Res 256(1):27\u201333. https:\/\/doi.org\/10.1006\/excr.2000.4835","journal-title":"Exp Cell Res"},{"issue":"2","key":"1978_CR13","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/s0092-8674(04)00046-7","volume":"116","author":"NN Danial","year":"2004","unstructured":"Danial NN, Korsmeyer SJ (2004) Cell death: critical control points. Cell 116(2):205\u2013219. https:\/\/doi.org\/10.1016\/s0092-8674(04)00046-7","journal-title":"Cell"},{"issue":"5381","key":"1978_CR14","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1126\/science.281.5381.1305","volume":"281","author":"A Ashkenazi","year":"1998","unstructured":"Ashkenazi A, Dixit VM (1998) Death receptors: signaling and modulation. Science 281(5381):1305\u20131308. https:\/\/doi.org\/10.1126\/science.281.5381.1305","journal-title":"Science"},{"issue":"1","key":"1978_CR15","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s10571-016-0360-5","volume":"37","author":"W Xu","year":"2017","unstructured":"Xu W, Jin W, Zhang X, Chen J, Ren C (2017) Remote limb preconditioning generates a neuroprotective effect by modulating the extrinsic apoptotic pathway and TRAIL-receptors expression. Cell Mol Neurobiol 37(1):169\u2013182. https:\/\/doi.org\/10.1007\/s10571-016-0360-5","journal-title":"Cell Mol Neurobiol"},{"issue":"3","key":"1978_CR16","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s00018-014-1757-2","volume":"72","author":"AV Zamaraev","year":"2015","unstructured":"Zamaraev AV, Kopeina GS, Zhivotovsky B, Lavrik IN (2015) Cell death controlling complexes and their potential therapeutic role. Cell Mol Life Sci 72(3):505\u2013517. https:\/\/doi.org\/10.1007\/s00018-014-1757-2","journal-title":"Cell Mol Life Sci"},{"issue":"2","key":"1978_CR17","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s10495-014-1060-6","volume":"20","author":"JK Yang","year":"2015","unstructured":"Yang JK (2015) Death effecter domain for the assembly of death-inducing signaling complex. Apoptosis 20(2):235\u2013239. https:\/\/doi.org\/10.1007\/s10495-014-1060-6","journal-title":"Apoptosis"},{"issue":"15\u201316","key":"1978_CR18","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.lfs.2011.02.004","volume":"88","author":"M Panneerselvam","year":"2011","unstructured":"Panneerselvam M, Patel PM, Roth DM, Kidd MW, Chin-Lee B, Head BP, Niesman IR, Inoue S et al (2011) Role of decoy molecules in neuronal ischemic preconditioning. Life Sci 88(15\u201316):670\u2013674. https:\/\/doi.org\/10.1016\/j.lfs.2011.02.004","journal-title":"Life Sci"},{"issue":"2\u20133","key":"1978_CR19","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/s0378-4274(02)00422-8","volume":"139","author":"M MacFarlane","year":"2003","unstructured":"MacFarlane M (2003) TRAIL-induced signalling and apoptosis. Toxicol Lett 139(2\u20133):89\u201397. https:\/\/doi.org\/10.1016\/s0378-4274(02)00422-8","journal-title":"Toxicol Lett"},{"issue":"7\u20138","key":"1978_CR20","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1016\/j.biocel.2007.02.007","volume":"39","author":"C Falschlehner","year":"2007","unstructured":"Falschlehner C, Emmerich CH, Gerlach B, Walczak H (2007) TRAIL signalling: decisions between life and death. Int J Biochem Cell Biol 39(7\u20138):1462\u20131475. https:\/\/doi.org\/10.1016\/j.biocel.2007.02.007","journal-title":"Int J Biochem Cell Biol"},{"issue":"1","key":"1978_CR21","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/sj.cdd.4401187","volume":"10","author":"HN LeBlanc","year":"2003","unstructured":"LeBlanc HN, Ashkenazi A (2003) Apo2L\/TRAIL and its death and decoy receptors. Cell Death Differ 10(1):66\u201375. https:\/\/doi.org\/10.1038\/sj.cdd.4401187","journal-title":"Cell Death Differ"},{"issue":"50","key":"1978_CR22","doi-asserted-by":"publisher","first-page":"18099","DOI":"10.1073\/pnas.0507329102","volume":"102","author":"L Clancy","year":"2005","unstructured":"Clancy L, Mruk K, Archer K, Woelfel M, Mongkolsapaya J, Screaton G, Lenardo MJ, Chan FK (2005) Preligand assembly domain-mediated ligand-independent association between TRAIL receptor 4 (TR4) and TR2 regulates TRAIL-induced apoptosis. Proc Natl Acad Sci U S A 102(50):18099\u201318104. https:\/\/doi.org\/10.1073\/pnas.0507329102","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"19","key":"1978_CR23","doi-asserted-by":"publisher","first-page":"7046","DOI":"10.1128\/MCB.00520-06","volume":"26","author":"D Merino","year":"2006","unstructured":"Merino D, Lalaoui N, Morizot A, Schneider P, Solary E, Micheau O (2006) Differential inhibition of TRAIL-mediated DR5-DISC formation by decoy receptors 1 and 2. Mol Cell Biol 26(19):7046\u20137055. https:\/\/doi.org\/10.1128\/MCB.00520-06","journal-title":"Mol Cell Biol"},{"issue":"2","key":"1978_CR24","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.3390\/ijms13022078","volume":"13","author":"R Zhang","year":"2012","unstructured":"Zhang R, Zhang H, Zhang Z, Wang T, Niu J, Cui D, Xu S (2012) Neuroprotective effects of pre-treatment with l-carnitine and acetyl-L-carnitine on ischemic injury in vivo and in vitro. Int J Mol Sci 13(2):2078\u20132090. https:\/\/doi.org\/10.3390\/ijms13022078","journal-title":"Int J Mol Sci"},{"issue":"8","key":"1978_CR25","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s00109-009-0484-x","volume":"87","author":"O Hoffmann","year":"2009","unstructured":"Hoffmann O, Zipp F, Weber JR (2009) Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) in central nervous system inflammation. J Mol Med (Berl) 87(8):753\u2013763. https:\/\/doi.org\/10.1007\/s00109-009-0484-x","journal-title":"J Mol Med (Berl)"},{"issue":"14","key":"1978_CR26","doi-asserted-by":"publisher","first-page":"2640","DOI":"10.1111\/febs.13598","volume":"283","author":"R Iurlaro","year":"2016","unstructured":"Iurlaro R, Munoz-Pinedo C (2016) Cell death induced by endoplasmic reticulum stress. FEBS J 283(14):2640\u20132652. https:\/\/doi.org\/10.1111\/febs.13598","journal-title":"FEBS J"},{"issue":"9","key":"1978_CR27","doi-asserted-by":"publisher","first-page":"e0136414","DOI":"10.1371\/journal.pone.0136414","volume":"10","author":"X Pan","year":"2015","unstructured":"Pan X, Pang M, Ma A, Wang K, Zhang Z, Zhong Q, Yang S (2015) Association of TRAIL and its receptors with large-artery atherosclerotic stroke. PLoS One 10(9):e0136414. https:\/\/doi.org\/10.1371\/journal.pone.0136414","journal-title":"PLoS One"},{"issue":"1","key":"1978_CR28","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1006\/bbrc.2002.6421","volume":"291","author":"SY Park","year":"2002","unstructured":"Park SY, Billiar TR, Seol DW (2002) Hypoxia inhibition of apoptosis induced by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). Biochem Biophys Res Commun 291(1):150\u2013153. https:\/\/doi.org\/10.1006\/bbrc.2002.6421","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"1978_CR29","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.tibs.2017.11.002","volume":"43","author":"E Lafont","year":"2018","unstructured":"Lafont E, Hartwig T, Walczak H (2018) Paving TRAIL\u2019s path with ubiquitin. Trends Biochem Sci 43(1):44\u201360. https:\/\/doi.org\/10.1016\/j.tibs.2017.11.002","journal-title":"Trends Biochem Sci"},{"issue":"3","key":"1978_CR30","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.cellsig.2009.11.012","volume":"22","author":"JJ Song","year":"2010","unstructured":"Song JJ, Szczepanski MJ, Kim SY, Kim JH, An JY, Kwon YT, Alcala MA Jr, Bartlett DL et al (2010) c-Cbl-mediated degradation of TRAIL receptors is responsible for the development of the early phase of TRAIL resistance. Cell Signal 22(3):553\u2013563. https:\/\/doi.org\/10.1016\/j.cellsig.2009.11.012","journal-title":"Cell Signal"},{"issue":"2","key":"1978_CR31","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1016\/j.bbrc.2009.12.058","volume":"391","author":"GT Pei","year":"2010","unstructured":"Pei GT, Wu CW, Lin WW (2010) Hypoxia-induced decoy receptor 2 gene expression is regulated via a hypoxia-inducible factor 1alpha-mediated mechanism. Biochem Biophys Res Commun 391(2):1274\u20131279. https:\/\/doi.org\/10.1016\/j.bbrc.2009.12.058","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"1978_CR32","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/sj.neo.7900270","volume":"4","author":"N Ozoren","year":"2002","unstructured":"Ozoren N, El-Deiry WS (2002) Defining characteristics of types I and II apoptotic cells in response to TRAIL. Neoplasia 4(6):551\u2013557. https:\/\/doi.org\/10.1038\/sj.neo.7900270","journal-title":"Neoplasia"},{"issue":"12","key":"1978_CR33","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/s0960-9822(06)00422-2","volume":"7","author":"SA Marsters","year":"1997","unstructured":"Marsters SA, Sheridan JP, Pitti RM, Huang A, Skubatch M, Baldwin D, Yuan J, Gurney A et al (1997) A novel receptor for Apo2L\/TRAIL contains a truncated death domain. Curr Biol 7(12):1003\u20131006. https:\/\/doi.org\/10.1016\/s0960-9822(06)00422-2","journal-title":"Curr Biol"},{"issue":"5","key":"1978_CR34","doi-asserted-by":"publisher","first-page":"e19679","DOI":"10.1371\/journal.pone.0019679","volume":"6","author":"N Lalaoui","year":"2011","unstructured":"Lalaoui N, Morle A, Merino D, Jacquemin G, Iessi E, Morizot A, Shirley S, Robert B et al (2011) TRAIL-R4 promotes tumor growth and resistance to apoptosis in cervical carcinoma HeLa cells through AKT. PLoS One 6(5):e19679. https:\/\/doi.org\/10.1371\/journal.pone.0019679","journal-title":"PLoS One"},{"key":"1978_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0083-6729(04)67001-4","volume":"67","author":"SS Cha","year":"2004","unstructured":"Cha SS, Song YL, Oh BH (2004) Specificity of molecular recognition learned from the crystal structures of TRAIL and the TRAIL:sDR5 complex. Vitam Horm 67:1\u201317. https:\/\/doi.org\/10.1016\/S0083-6729(04)67001-4","journal-title":"Vitam Horm"},{"issue":"10","key":"1978_CR36","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1517\/14728222.2010.519701","volume":"14","author":"J Abdulghani","year":"2010","unstructured":"Abdulghani J, El-Deiry WS (2010) TRAIL receptor signaling and therapeutics. Expert Opin Ther Targets 14(10):1091\u20131108. https:\/\/doi.org\/10.1517\/14728222.2010.519701","journal-title":"Expert Opin Ther Targets"},{"issue":"3","key":"1978_CR37","first-page":"160","volume":"34","author":"RN Crowder","year":"2012","unstructured":"Crowder RN, El-Deiry WS (2012) Caspase-8 regulation of TRAIL-mediated cell death. Exp Oncol 34(3):160\u2013164","journal-title":"Exp Oncol"},{"issue":"2","key":"1978_CR38","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.canlet.2010.07.022","volume":"332","author":"DG Stupack","year":"2013","unstructured":"Stupack DG (2013) Caspase-8 as a therapeutic target in cancer. Cancer Lett 332(2):133\u2013140. https:\/\/doi.org\/10.1016\/j.canlet.2010.07.022","journal-title":"Cancer Lett"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-020-01978-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-020-01978-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-020-01978-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,19]],"date-time":"2021-06-19T23:13:58Z","timestamp":1624144438000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-020-01978-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,20]]},"references-count":38,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["1978"],"URL":"https:\/\/doi.org\/10.1007\/s12035-020-01978-3","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,20]]},"assertion":[{"value":"22 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}